Goserelin: profile and news

Procyon Shareholders Approve Cellpep Acquisition  Feb 27, 2006
...in the US in 2008. The second product, Goserelin, is expected to be launched in Europe in 2008. "Today's vote confirmed the strong ... - International News Service,

Procyon Announces the Completion of the Acquisition of Cellpep SA ...  Mar 1, 2006
The second product, Goserelin, is expected to be launched in Europe in 2008. With these late-stage products, Ambrilia Biopharma ... - PharmaLive.com (press release),

Repeat/Media Advisory: Procyon' Special Meeting of Shareholders ...  Feb 22, 2006
The second product, goserelin, is expected to be launched in Europe in 2008. With this combined portfolio comprised of high-value ... - CCNMatthews (press release),

Gonadotropin-Releasing Hormone Anologue Prevents Ovarian Failure ...  Feb 8, 2006
Researchers from Italy have reported that the administration of the gonadotropin releasing hormone analogue goserelin (Gn-RH) prevents ovarian failure in women ... - Cancer Consultants (press release),

Procyon Presents Preclinical Results with its Novel Tumor ...  Feb 7, 2006
The second product, goserelin, is expected to be launched in Europe in 2008. With this combined portfolio comprised of high-value ... - CCNMatthews (press release),

Ovarian Suppression During Chemotherapy May Protect Ovarian ...  Jan 27, 2006
...first dose of the GnRH analogue. The GnRH analogue used in this study was Zoladex® (goserelin). Patients enrolled at the beginning ... - Cancer Consultants (press release),

Procyon Biopharma to Acquire Cellpep SA  Jan 19, 2006
Cellpep is also developing goserelin, an improved version of a prostate cancer drug as well as a fusion inhibitor for HIV and several other peptides. ... - TechFinance,

New Data Show Survival Benefit for Arimidex(TM) in Early Breast ...  Dec 9, 2005
...including 'ARIMIDEX' (anastrozole), 'CASODEX' (bicalutamide), 'FASLODEX' (fulvestrant), 'NOLVADEX' (tamoxifen), 'ZOLADEX' (goserelin), 'TOMUDEX' (raltitrexed ... - news aktuell (Pressemitteilung),

Prostate cancer: awaiting innovation  Dec 8, 2005
...hormone (LHRH) agonist monotherapy remains the most commonly used drug therapy for prostate cancer, and agents such as leuprolide and goserelin are considered ... - Pharmaceutical Business Review

AstraZeneca Provides Additional Support to Hurricane Victims  Nov 17, 2005
...inhalation powder), RHINOCORT AQUA® (budesonide), SEROQUEL® (quetiapine fumarate), TOPROL-XL® (metoprolol succinate), ZOLADEX® (goserelin acetate implant ... - Yahoo! News (press release)

AstraZeneca Provides Additional Support to Hurricane Victims  Nov 17, 2005
...powder), RHINOCORT AQUA(R) (budesonide), SEROQUEL(R) (quetiapine fumarate), TOPROL-XL(R) (metoprolol succinate), ZOLADEX(R) (goserelin acetate implant), ZOMIG(R ... - PR Newswire (press release),

Phase II Trial Suggests Benefit of Hormonal Therapy for Recurrent ...  Oct 20, 2005
...results of a phase II clinical trial published in the British Journal of Cancer, the combination of Nolvadex® (tamoxifen) and Zoladex® (goserelin) was well ... - Cancer Consultants (press release),

Nolvadex® and Zoladex® Effective Palliation for Recurrent ...  Oct 19, 2005
50% of patients with recurrent ovarian cancer had disease control for six months or more following treatment with Nolvadex (tamoxifen) and Zoladex (goserelin). ... - Cancer Consultants (press release),

Short-Term Hormone Therapy Can Improve Outlook for Early Prostate ...  Oct 5, 2005
When compared with men treated by radiotherapy alone, men treated with three months of goserelin and flutamide prior to and during radiotherapy had a 35% lower ... - Newswise (press release)

Hormonal Therapy Added to Radiation Improves Prostate Cancer ...  Oct 5, 2005
...in a larger clinical trial, they conducted a study comparing radiotherapy alone to radiotherapy plus androgen deprivation with Zoladex (goserelin) and Eulexin ... - MedPage Today,

Call to relax PBS restriction  Oct 11, 2005
Men treated with six months of goserelin (Zoladex) and flutamide (Eulexin) before and during radiotherapy had their risk of relapse reduced by 44% compared ... - AustralianDoctor.com (subscription),

Call to relax PBS restriction  11 Oct 2005
Men treated with six months of goserelin (Zoladex) and flutamide (Eulexin) before and during radiotherapy had their risk of relapse reduced by 44% compared ... - AustralianDoctor.com (subscription),

Short-Term Hormone Therapy Can Improve Outlook for Early Prostate ...  Oct 5, 2005
When compared with men treated by radiotherapy alone, men treated with three months of goserelin and flutamide prior to and during radiotherapy had a 35% lower ... - Newswise (press release)

Hormonal Therapy Added to Radiation Improves Prostate Cancer ...  Oct 5, 2005
...in a larger clinical trial, they conducted a study comparing radiotherapy alone to radiotherapy plus androgen deprivation with Zoladex (goserelin) and Eulexin ... - MedPage Today,

AstraZeneca Receive Highly Coveted Frost & Sullivan Award ...  Sep 20, 2005
...including 'ARIMIDEX' (anastrozole), 'CASODEX' (bicalutamide), 'FASLODEX' (fulvestrant), 'NOLVADEX' (tamoxifen), 'ZOLADEX' (goserelin), 'TOMUDEX' (raltitrexed ... - PR Newswire (press release),

New International Treatment Guidelines Verify Crucial Role of ' ...  Sep 7, 2005
...including 'ARIMIDEX' (anastrozole), 'CASODEX' (bicalutamide), 'FASLODEX' (fulvestrant), 'NOLVADEX' (tamoxifen), 'ZOLADEX' (goserelin), 'TOMUDEX' (raltitrexed ... - news aktuell (Pressemitteilung),

AstraZeneca Pledges More Than $1 Million in Contributions and ...  Sep 1, 2005
...inhalation powder), RHINOCORT AQUA® (budesonide), SEROQUEL® (quetiapine fumarate), TOPROL-XL® (metoprolol succinate), ZOLADEX® (goserelin acetate implant ... - Yahoo! News (press release)

AstraZeneca Pledges More Than $1 Million in Contributions and ...  Sep 1, 2005
...powder), RHINOCORT AQUA(R) (budesonide), SEROQUEL(R) (quetiapine fumarate), TOPROL-XL(R) (metoprolol succinate), ZOLADEX(R) (goserelin acetate implant), ZOMIG(R ... - PR Newswire (press release),

Data Confirm Postmenopausal Women Taking Adjuvant Tamoxifen for ...  Aug 4, 2005
...including 'ARIMIDEX' (anastrozole), 'CASODEX' (bicalutamide), 'FASLODEX' (fulvestrant), 'NOLVADEX' (tamoxifen), 'ZOLADEX' (goserelin), 'TOMUDEX' (raltitrexed ... - Presseportal (Pressemitteilung)

CMS Issues Interim Final Rule on Competitive Acquisition of ...  Jul 19, 2005
...an LCA policy to injectable forms of leuprolide, which would have the effect of requiring vendors to supply the drug at the cost of goserelin regardless of the ... - Mondaq News Alerts <**results**>

Studies of Bone Health  Jun 30, 2005
These include medicines that shut down the ovary and its production of estrogen, such as Zoladex (chemical name: goserelin) and Lupron (chemical name ... - Breastcancer.org,